Sugi Predict

Sugi Predict / Compounds / SCHEMBL102840

SCHEMBL102840

SCHEMBL102840

N#CCc1cccc(OC(F)(F)F)c1

nearest known ligand 0.48

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ CETP P11597 5/20 0.48
▸ CHRM2 P08172 1/20 0.47
▸ CHRM1 P11229 1/20 0.47
▸ CHRM3 P20309 1/20 0.47
▸ DAO P14920 1/20 0.46
▸ ENPP2 Q13822 1/20 0.45
▸ MAPK14 Q16539 1/20 0.43
▸ MMP3 P08254 1/20 0.42
▸ CTSS P25774 1/20 0.41
▸ CTSK P43235 1/20 0.41
▸ FFAR1 O14842 1/20 0.41
▸ CARM1 Q86X55 2/20 0.40
▸ PRMT6 Q96LA8 2/20 0.40
▸ CNR1 P21554 1/20 0.40
▸ TACR1 P25103 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7038656 0.83 MEN1 (0.59) CETPCHRM2CHRM1CHRM3DAO
SCHEMBL18356495 0.83 CETP (0.48) CETPCHRM2CHRM1CHRM3DAO
SCHEMBL5543805 0.83 CETP (0.51) CETPCHRM2CHRM1CHRM3DAO
SCHEMBL24133957 0.82 TDP1 (0.36) CETPCHRM2CHRM1CHRM3DAO
SCHEMBL5009648 0.80 DAO (0.55) CETPCHRM2CHRM1CHRM3DAO
SCHEMBL5176295 0.79 MEP1B (0.47) DAOENPP2MMP3FFAR1
SCHEMBL6825291 0.79 CETP (0.48) CETPCHRM2CHRM1CHRM3DAO
SCHEMBL178310 0.78 CHRM2 (0.55) CETPCHRM2CHRM1CHRM3DAO
SCHEMBL19062249 0.78 CETP (0.53) CETPCHRM2CHRM1CHRM3DAO
SCHEMBL549086 0.78 ALDH1A1 (0.44) DAO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 98 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250320217-A1 SUBSTITUTED IMIDAZO[1,2-B]PYRIDAZINES AS PROTEIN KINASE INHIBITORS SUMITOMO PHARMA AMERICA INC (US) 2025-10-16 — — US disclosed
US-20250129085-A1 SUBSTITUTED IMIDAZO[1,2-B]PYRIDAZINES AS PROTEIN KINASE INHIBITORS SUMITOMO PHARMA AMERICA INC (US) 2025-04-24 — — US disclosed
US-20250034143-A1 SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF HYDRA BIOSCIENCES, LLC (US) 2025-01-30 — — US disclosed
WO-2024174980-A1 COMPOUND CONTAINING DIHYDROPHTHALAZINE AND ALKENYL AND USE THEREOF 正大天晴药业集团股份有限公司 2024-08-29 — — WO disclosed
US-11958854-B2 Substituted xanthines and methods of use thereof HYDRA BIOSCIENCES, LLC (US) 2024-04-16 — — US disclosed
CN-116368112-A Novel potassium channel inhibitors 萨尼奥纳有限责任公司 2023-06-30 — — CN disclosed
CN-113717156-B EGFR inhibitor, preparation method and application thereof 南京红云生物科技有限公司 2023-05-09 — — CN disclosed
US-20230040259-A1 SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF HYDRA BIOSCIENCES, LLC (US) 2023-02-09 — — US disclosed
CN-115697996-A Alkenyl pyrimidine compound, preparation method and application thereof 南京红云生物科技有限公司 2023-02-03 — — CN disclosed
CN-115636743-A Preparation method of phenylacetic acid compound 上海历赢生物科技有限公司 2023-01-24 — — CN disclosed
US-6465485-B1 SUCH AS 7-CYANO-2-(2-(1-(4-(2-INDOLYL)CARBOXAMIDO)CYCLO-HEXYL)ETHYL)-1,2,3,4 -TETRAHYDROISOQUINOLINE; ANTIPSYCHOTIC AGENTS SMITHKLINE BEECHAM P.L.C. (GB) 2002-10-15 — — US disclosed
US-6274593-B1 TREATING PSYCHOLOGICAL DISORDERS, SCHIZOPHRENIA, AND PARKINSON*S DISEASE SMITHKLINE BEECHAM P.L.C. (GB) 2001-08-14 — — US disclosed
CN-1261350-A Tetrahydroisoquinoline derivatives as modulators of the dopamine D3 receptor SMITHKLINE BEECHAM PLC (GB) 2000-07-26 — — CN disclosed
EP-0983244-A1 TETRAHYDROISOQUINOLINE DERIVATIVES AS MODULATORS OF DOPAMINE D3 RECEPTORS SMITHKLINE BEECHAM PLC (GB) 2000-03-08 — — EP disclosed
EP-0980357-A1 SUBSTITUTED TETRAHYDRO ISOQUINOLINES AS MODULATORS OF DOPAMINE D3 RECEPTORS SMITHKLINE BEECHAM PLC (GB) 2000-02-23 — — EP disclosed
WO-1998050364-A1 TETRAHYDROISOQUINOLINE DERIVATIVES AS MODULATORS OF DOPAMINE D3 RECEPTORS SMITHKLINE BEECHAM PLC (GB) 1998-11-12 — — WO disclosed
WO-1998050363-A1 SUBSTITUTED TETRAHYDRO ISOQUINOLINES AS MODULATORS OF DOPAMINE D3 RECEPTORS SMITHKLINE BEECHAM PLC (GB) 1998-11-12 — — WO disclosed
CN-1103866-A Nes pesticides RHONE POULENC AGRICULTURE (GB) 1995-06-21 — — CN disclosed
EP-0634404-A1 Phtalazin derivatives and their use as pesticides RHONE POULENC AGRICULTURE LTD. (GB) 1995-01-18 — — EP disclosed
EP-0216166-A1 3,5-Disubstituted 4-pyridones BAYER AG (DE) 1987-04-01 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250129085-A1 SUBSTITUTED IMIDAZO[1,2-B]PYRIDAZINES AS PROTEIN KINASE INHIBITORS PIM1, PIM2, PIM3 CETP 4455/4885CHRM2 2125/4885CHRM1 1251/4885
US-11958854-B2 Substituted xanthines and methods of use thereof TRPC5, TRPC7, TRPC4 CETP 2815/4885CHRM2 1940/4885CHRM1 2229/4885
US-20230040259-A1 SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF TRPC5, TRPC7, TRPC4 CETP 2815/4885CHRM2 1940/4885CHRM1 2229/4885
US-20250034143-A1 SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF TRPC5, TRPC7, TRPC4 CETP 2815/4885CHRM2 1940/4885CHRM1 2229/4885
US-20250320217-A1 SUBSTITUTED IMIDAZO[1,2-B]PYRIDAZINES AS PROTEIN KINASE INHIBITORS PIM1, PIM2, PIM3 CETP 4455/4885CHRM2 2125/4885CHRM1 1251/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.